News
Decarbonization to lead profitable growth in Europe
Swiss Re reports net income of USD 2.5 billion for first nine months of 2023
AEVIS VICTORIA SA – Continued organic growth in the third quarter of 2023
Strong earnings growth in the third quarter
Sales and Margins Impacted by Weak End Markets; Focusing on Cost Containment and Strong Technology Pipeline; Long-Term Demand Drivers Intact
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
Healthcare companies are spending big on developing treatments for inflammatory bowel disease (IBD), which consists of either Crohn's disease or ulcerative colitis (UC), or both. The lure for IBD
2 Green Flags and 1 Red Flag for Novartis Stock
Share prices of Swiss pharmaceutical company Novartis (NYSE: NVS) have climbed more than 10% so far this year. The company focuses on cardiovascular, immunology, neuroscience, solid tumors, and
Continued Profitable Growth in Q3 with Record Recurring EBIT
Novartis Ag (NVS) Q3 2023 Earnings Call Transcript
Kudelski IoT Solves Misplaced Car Key Woes for Consumers and Dealerships with Launch of 'RecovR for Keys'
Q3 2023 results
2 Biotech Stocks That Could Make You Richer
Although sometimes risky and volatile, the biotech industry is an excellent place to find stocks that can generate steady returns for years. That's because these companies tend to offer products
3 Unstoppable Stocks to Buy and Hold for Decades
Want to invest in stocks that you can buy and forget about? If so, you'll want to consider companies with plenty of long-term growth opportunities and solid financials. Among the best growth